Serum neutralizing antibodies induced by parenteral immunization need to transudate across the respiratory mucosa to prevent infection with SARS-CoV-2, whereas local IgG and IgA induced by respiratory infection or nasal vaccine may provide a more efficient first line of defense against respiratory pathogens. The gene discussed is CD79A; the disease is infection.